Alex Zhavoronkov, Insilico CEO
No humans allowed: Alex Zhavoronkov adds robotic lab to his AI drug discovery play as Insilico unveils $60M raise
For Alex Zhavoronkov, the recent biotech market downturn is, in fact, a good thing.
The Insilico CEO — in his signature confident exuberance — said the crisis …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
